1. Home
  2. NNNN vs PFL Comparison

NNNN vs PFL Comparison

Compare NNNN & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • PFL
  • Stock Information
  • Founded
  • NNNN 2021
  • PFL 2003
  • Country
  • NNNN Germany
  • PFL United States
  • Employees
  • NNNN N/A
  • PFL N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PFL Finance Companies
  • Sector
  • NNNN Health Care
  • PFL Finance
  • Exchange
  • NNNN Nasdaq
  • PFL Nasdaq
  • Market Cap
  • NNNN 369.6M
  • PFL 374.1M
  • IPO Year
  • NNNN 2025
  • PFL N/A
  • Fundamental
  • Price
  • NNNN $49.26
  • PFL $8.30
  • Analyst Decision
  • NNNN
  • PFL
  • Analyst Count
  • NNNN 0
  • PFL 0
  • Target Price
  • NNNN N/A
  • PFL N/A
  • AVG Volume (30 Days)
  • NNNN 220.1K
  • PFL 113.7K
  • Earning Date
  • NNNN 01-01-0001
  • PFL 01-01-0001
  • Dividend Yield
  • NNNN N/A
  • PFL 11.53%
  • EPS Growth
  • NNNN N/A
  • PFL N/A
  • EPS
  • NNNN 0.06
  • PFL N/A
  • Revenue
  • NNNN $8,185,146.00
  • PFL N/A
  • Revenue This Year
  • NNNN N/A
  • PFL N/A
  • Revenue Next Year
  • NNNN N/A
  • PFL N/A
  • P/E Ratio
  • NNNN $908.77
  • PFL N/A
  • Revenue Growth
  • NNNN 21.95
  • PFL N/A
  • 52 Week Low
  • NNNN $5.18
  • PFL $6.98
  • 52 Week High
  • NNNN $53.11
  • PFL $8.62
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • PFL 46.29
  • Support Level
  • NNNN N/A
  • PFL $8.31
  • Resistance Level
  • NNNN N/A
  • PFL $8.42
  • Average True Range (ATR)
  • NNNN 0.00
  • PFL 0.05
  • MACD
  • NNNN 0.00
  • PFL 0.00
  • Stochastic Oscillator
  • NNNN 0.00
  • PFL 33.33

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

Share on Social Networks: